Published in
Taylor and Francis Group, Expert Opinion on Biological Therapy, 1-2(24), p. 51-62, 2024
DOI: 10.1080/14712598.2024.2311750
Links
Tools
Pembrolizumab for metastatic castration-resistant prostate cancer: trials and tribulations
Journal article published in 2024 by
Alexander K. Tsai 
,
Sana Kagalwalla,
Jenna Langer,
Thuy Le-Kumar,
Vikas Le-Kumar,
Emmanuel S. Antonarakis
,
Sana Kagalwalla,
Jenna Langer,
Thuy Le-Kumar,
Vikas Le-Kumar,
Emmanuel S. Antonarakis
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 